Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target.

Apps JR, Carreno G, Gonzalez-Meljem JM, Haston S, Guiho R, Cooper JE, Manshaei S, Jani N, Hölsken A, Pettorini B, Beynon RJ, Simpson DM, Fraser HC, Hong Y, Hallang S, Stone TJ, Virasami A, Donson AM, Jones D, Aquilina K, Spoudeas H, Joshi AR, Grundy R, Storer LCD, Korbonits M, Hilton DA, Tossell K, Thavaraj S, Ungless MA, Gil J, Buslei R, Hankinson T, Hargrave D, Goding C, Andoniadou CL, Brogan P, Jacques TS, Williams HJ, Martinez-Barbera JP.

Acta Neuropathol. 2018 May;135(5):757-777. doi: 10.1007/s00401-018-1830-2. Epub 2018 Mar 14.

2.

Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation.

Sekine S, Takata T, Shibata T, Mori M, Morishita Y, Noguchi M, Uchida T, Kanai Y, Hirohashi S.

Histopathology. 2004 Dec;45(6):573-9.

PMID:
15569047
3.

Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma.

Andoniadou CL, Gaston-Massuet C, Reddy R, Schneider RP, Blasco MA, Le Tissier P, Jacques TS, Pevny LH, Dattani MT, Martinez-Barbera JP.

Acta Neuropathol. 2012 Aug;124(2):259-71. doi: 10.1007/s00401-012-0957-9. Epub 2012 Feb 18.

4.

Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma.

Donson AM, Apps J, Griesinger AM, Amani V, Witt DA, Anderson RCE, Niazi TN, Grant G, Souweidane M, Johnston JM, Jackson EM, Kleinschmidt-DeMasters BK, Handler MH, Tan AC, Gore L, Virasami A, Gonzalez-Meljem JM, Jacques TS, Martinez-Barbera JP, Foreman NK, Hankinson TC; Advancing Treatment for Pediatric Craniopharyngioma Consortium.

J Neuropathol Exp Neurol. 2017 Sep 1;76(9):779-788. doi: 10.1093/jnen/nlx061.

5.

The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis.

Preda V, Larkin SJ, Karavitaki N, Ansorge O, Grossman AB.

Endocr Pathol. 2015 Mar;26(1):1-8. doi: 10.1007/s12022-014-9341-8.

PMID:
25355426
6.

Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models.

Martinez-Barbera JP, Buslei R.

J Pediatr Endocrinol Metab. 2015 Jan;28(1-2):7-17. doi: 10.1515/jpem-2014-0442. Review.

PMID:
25503464
7.

Potential evolution of neurosurgical treatment paradigms for craniopharyngioma based on genomic and transcriptomic characteristics.

Robinson LC, Santagata S, Hankinson TC.

Neurosurg Focus. 2016 Dec;41(6):E3. Review.

PMID:
27903126
8.

Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma.

Martinez-Barbera JP.

Neuropathol Appl Neurobiol. 2015 Oct;41(6):721-32. doi: 10.1111/nan.12226. Epub 2015 Apr 23. Review.

9.

Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas.

Buslei R, Hölsken A, Hofmann B, Kreutzer J, Siebzehnrubl F, Hans V, Oppel F, Buchfelder M, Fahlbusch R, Blümcke I.

Acta Neuropathol. 2007 May;113(5):585-90. Epub 2007 Jan 13.

PMID:
17221204
10.

Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin.

Stache C, Bils C, Fahlbusch R, Flitsch J, Buchfelder M, Stefanits H, Czech T, Gaipl U, Frey B, Buslei R, Hölsken A.

Neurosurg Focus. 2016 Dec;41(6):E14.

PMID:
27903123
11.

Comparative immunohistochemical expression of β-catenin, EGFR, ErbB2, and p63 in adamantinomatous and papillary craniopharyngiomas.

Esheba GE, Hassan AA.

J Egypt Natl Canc Inst. 2015 Sep;27(3):139-45. doi: 10.1016/j.jnci.2015.06.003. Epub 2015 Jul 18.

12.

Pathology and pathogenesis of craniopharyngiomas.

Larkin SJ, Ansorge O.

Pituitary. 2013 Mar;16(1):9-17. doi: 10.1007/s11102-012-0418-4. Review.

PMID:
22886701
13.

SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma.

Carreno G, Boult JKR, Apps JR, Gonzalez-Meljem JM, Haston S, Guiho R, Stache C, Danielson LS, Koers A, Smith LS, Virasami A, Panousopoulos L, Buchfelder M, Jacques TS, Chesler L, Robinson S, Martinez-Barbera JP.

Endocr Relat Cancer. 2019 Jan 1. pii: ERC-18-0538.R1. doi: 10.1530/ERC-18-0538. [Epub ahead of print]

14.

Differential Expression of Stem Cell Markers in Human Adamantinomatous Craniopharyngioma and Pituitary Adenoma.

Chang CV, Araujo RV, Cirqueira CS, Cani CM, Matushita H, Cescato VA, Fragoso MC, Bronstein MD, Zerbini MC, Mendonca BB, Carvalho LR.

Neuroendocrinology. 2017;104(2):183-193. Epub 2016 Apr 29.

15.

Genomic Alterations of Adamantinomatous and Papillary Craniopharyngioma.

Goschzik T, Gessi M, Dreschmann V, Gebhardt U, Wang L, Yamaguchi S, Wheeler DA, Lauriola L, Lau CC, Müller HL, Pietsch T.

J Neuropathol Exp Neurol. 2017 Feb 1;76(2):126-134. doi: 10.1093/jnen/nlw116.

PMID:
28069929
16.

Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas.

Hölsken A, Kreutzer J, Hofmann BM, Hans V, Oppel F, Buchfelder M, Fahlbusch R, Blümcke I, Buslei R.

Brain Pathol. 2009 Jul;19(3):357-64. doi: 10.1111/j.1750-3639.2008.00180.x. Epub 2008 May 29.

PMID:
18540944
17.

Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling.

Hölsken A, Buchfelder M, Fahlbusch R, Blümcke I, Buslei R.

Acta Neuropathol. 2010 May;119(5):631-9. doi: 10.1007/s00401-010-0642-9. Epub 2010 Feb 4.

PMID:
20131060
18.

Sonic Hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas.

Gomes DC, Jamra SA, Leal LF, Colli LM, Campanini ML, Oliveira RS, Martinelli CE Jr, Elias PC, Moreira AC, Machado HR, Saggioro F, Neder L, Castro M, Antonini SR.

Eur J Endocrinol. 2015 May;172(5):603-8. doi: 10.1530/EJE-14-0934. Epub 2015 Feb 18.

PMID:
25693592
19.

Impact of the Canonical Wnt Pathway Activation on the Pathogenesis and Prognosis of Adamantinomatous Craniopharyngiomas.

Jucá CEB, Colli LM, Martins CS, Campanini ML, Paixão B, Jucá RV, Saggioro FP, de Oliveira RS, Moreira AC, Machado HR, Neder L, Antonini SR, de Castro M.

Horm Metab Res. 2018 Jul;50(7):575-581. doi: 10.1055/a-0593-5956. Epub 2018 Apr 6.

PMID:
29625497
20.

60 YEARS OF NEUROENDOCRINOLOGY: Biology of human craniopharyngioma: lessons from mouse models.

Martinez-Barbera JP.

J Endocrinol. 2015 Aug;226(2):T161-72. doi: 10.1530/JOE-15-0145. Epub 2015 Apr 29. Review.

PMID:
25926515

Supplemental Content

Support Center